Based on the intense uptake of SST analogues by metastatic lesions, the authors took a step further and administered adjuvant peptide receptor radionuclide therapy (PRRNT) with 177Lu-DOTATATE in combination with doxorubicin chemotherapy, implementing the first documented ‘theranostic’ strategy in MCC management. Here, SST is linked to Merkel cell skin cancer.